Home/Filings/4/0001415889-24-019463
4//SEC Filing

Ross Thomas M. 4

Accession 0001415889-24-019463

CIK 0001287098other

Filed

Jul 9, 8:00 PM ET

Accepted

Jul 10, 4:15 PM ET

Size

14.9 KB

Accession

0001415889-24-019463

Insider Transaction Report

Form 4
Period: 2024-07-08
Ross Thomas M.
EVP, Global Sales
Transactions
  • Sale

    Common Stock

    2024-07-08$4.03/sh19,802$79,78225,000 total
  • Exercise/Conversion

    Common Stock

    2024-07-08$1.64/sh+19,802$32,49544,802 total
  • Exercise/Conversion

    Common Stock

    2024-07-09$1.64/sh+13,531$22,20438,531 total
  • Sale

    Common Stock

    2024-07-09$4.03/sh13,531$54,58425,000 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2024-07-0819,80246,865 total
    Exercise: $1.64Exp: 2030-01-20Common Stock (19,802 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2024-07-0913,53133,334 total
    Exercise: $1.64Exp: 2030-01-20Common Stock (13,531 underlying)
Footnotes (4)
  • [F1]The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024.
  • [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.00 to $4.055, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.00 to $4.105, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The option has fully vested.

Issuer

MAXCYTE, INC.

CIK 0001287098

Entity typeother

Related Parties

1
  • filerCIK 0001874572

Filing Metadata

Form type
4
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 4:15 PM ET
Size
14.9 KB